Trial Profile
Aliskiren in VIsceral obesity AT risk patients Outcomes Research
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2008
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Cardiovascular disorders; Hypertension
- Focus Registrational; Therapeutic Use
- Acronyms ASPIRE-HIGHER; AVIATOR
- 03 Jun 2008 New trial record.